$GROW

U.S. Global Investors Announces Intent to Restate EPS for the March 31, 2026, Financial Statements; Underlying Financial Results Unchanged

U.S. Global Investors (NASDAQ: GROW) said it will restate EPS for the three- and nine-month periods ended March 31, 2026, due to a miscalculation of basic and diluted weighted-average shares that omitted a component in a supporting spreadsheet. The company said net income, revenues, operating income, cash, and other line items are unchanged. For the quarter, EPS was overstated by $0.02; corrected basic/diluted EPS is $0.21. For nine months, overstated by $0.01; corrected EPS is reflected in an a

Original reporting
Published Jun 1, 2026, 11:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 11:45 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
U.S. Global Investors Announces Intent to Restate EPS for the March 31, 2026, Financial Statements; Underlying Financial Results Unchanged — source image
Decision brief

The 30-second read

$GROWNeutralMed
01

Why it matters

The key trading variable is whether the market treats this as purely clerical (limited impact) or as a broader earnings-quality/control issue (potential multiple compression). The amended filing timing is the next concrete catalyst.

02

Market read

Traders may reassess near-term valuation and per-share expectations ahead of the amended filing, despite unchanged underlying earnings power.

03

What to watch

Per-share metrics tied to buybacks/dividend coverage and any covenant or model inputs could require recalibration even if the restatement is “only” EPS.

Relevance 8/10Novelty 6/10Timing: Ahead of the company’s amended Form 10-Q/A filing

Background

U.S. Global Investors identified an omission in a supporting spreadsheet that understated weighted-average shares, overstating EPS for periods ended March 31, 2026; it will file a Form 10-Q/A to amend prior disclosures.

Company-level read

Ticker impact

$GROWNeutralMedium confidence
Context

U.S. Global Investors plans an EPS restatement for the quarter and nine months ended March 31, 2026 due to a weighted-share miscalculation.

Expected impact

Likely limited fundamental impact; near-term volatility possible as investors re-anchor EPS and assess governance/controls risk.

Evidence & confidence

The company states only weighted-average shares and EPS are affected, with underlying financial statement line items unchanged, reducing fundamental downside but not eliminating market reaction risk.

Market effects

Minor read-through to closed-end/asset-manager reporting quality; could modestly increase attention to EPS calculation controls among small-cap RIAs.

Primarily affects U.S. small-cap asset management sentiment; no explicit regional spillover cited.

Low—event is company-specific and not tied to global macro or cross-border operations.

Counterpoint

Because net income and revenue are unchanged, the restatement may be largely ignored by fundamental investors once the amended filing confirms no other adjustments.

Key entities

  • U.S. Global Investors, Inc.

    Announced intent to restate EPS for periods ended March 31, 2026 due to weighted-average share miscalculation; underlying financial statement line items unchanged.

  • Frank Holmes

    CEO and CIO who characterized the issue as clerical and cited enhancements to review procedures.

  • SEC Form 10-Q/A

    Amended quarterly filing the company intends to submit to reflect corrected EPS and share counts.

Related articles

$GROWLow

U S GLOBAL INVESTORS INC (GROW): Results of Operations and Financial Condition

U S GLOBAL INVESTORS INC (GROW) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_973695.htm EXHIBIT 99.1 ex_973695.htm Exhibit 99.1 Contact: Holly Schoenfeldt Director of Marketing and Public Relations 210.308.1268 hschoenfeldt@usfunds.com For Immediate Release U.S. Global Investors Announces Restatement of EPS for Q3 2026; Reported Financial Str

$SMCIMed

Super Micro Computer Landed $60 Billion in Orders Last Quarter, but Trades at Just $30

Super Micro Computer (SMCI) said it booked over $60B in new orders in its fiscal Q4 ended June 30, lifting backlog to a record. It guided FY2026 revenue near the low end of $11B to $12.5B and gross margins at 15% to 17%. The company also plans $7B equity financing for AI server orders, noting some orders may not be firm and citing an independent review tied to export control issues.

$CSCOMed

Cisco Stock Is Finally Pricing In A New Growth Story

Cisco raised full-year revenue and EPS guidance on May 13, 2026, citing AI infrastructure demand. Management expects about $9 billion in FY2026 AI orders from hyperscalers and cited 5 hyperscaler design wins in Q3. Cisco shares rose about 20% since, with product orders up 19% YoY excluding hyperscaler growth. Options imply 41% IV ahead of the next catalyst.

$RMDMed

Off Into Weekend, As Early Work Undone

ResMed (ASX:RMD) fell 8.29% on Friday and is 3.09% lower for the week after a strong run. The company reported a solid Q4, with FY26 revenue up 10% to $5.7b, gross Q4 margin 62.3%, FY EPS up 17% to $11.17, and a 10% dividend increase to $0.66. Morgan Stanley downgraded to Equal Weight and cut its price target, citing cooling growth and Philips’ potential US return in 2027.